Benjamin M. Johnson

This researcher's publication record spans two distinct areas: gut microbiota interactions with autoimmune diseases like type 1 diabetes and lupus in mouse models, and medicinal chemistry work on drug discovery and metabolism (including cancer immunotherapy targets and neuropathic pain treatments). The work combines laboratory immunology studies of intestinal bacteria and immune responses with pharmaceutical chemistry research on drug candidates and their properties. This dual focus suggests involvement in both basic biomedical research and applied pharmaceutical development, likely reflecting a career that has moved between academic and industry research settings.

Publication output was relatively high and variable earlier in the decade (2017-2020, peaking at 12 in 2020) but has slowed considerably in recent years, averaging under 3 papers per year since 2021.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026